Roche/Ventana
This article was originally published in The Gray Sheet
Executive Summary
Roche completes $3.4 billion acquisition of tissue-based cancer test maker Ventana Medical Systems Feb. 19. The firms inked the definitive $89.50-per-share merger deal Jan. 21 (1"The Gray Sheet" Jan. 28, 2008, p. 4)